Evidence map›Paper›PMID 31116070›Full record

ReviewExpert review of vaccines2019

Challenges in estimating influenza vaccine effectiveness.

Kylie E C Ainslie, Michael Haber, Walt A Orenstein

Open access · greenAbstract readReview
In one paragraph

Review in Expert review of vaccines, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Observational
  5. Article
  6. Article
  7. Estimated impact of 2022-2023 influenza vaccines on annual hospital burden in the United States.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. Article
  10. Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022-2023: A Prospective Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Kylie E C Ainsliea MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology , School of Public Health, Imperial College London , London , UK.ORCID 0000-0001-5419-7206
Michael Haberb Department of Biostatistics and Bioinformatics , Rollins School of Public Health, Emory University , Atlanta , GA , USA.
Walt A Orensteinc Division of Infectious Diseases, Department of Medicine , School of Medicine, Emory University , Atlanta , GA , USA.
Emory University · USImperial College London · GB

Funding

Study Designs for Estimating the Effectiveness of Vaccination Against InfluenzaR01AI110474 · NIAID · EMORY UNIVERSITY · PI HABER, MICHAEL J · 2014 to 2016
$858k
NIAID NIH HHS R01 AI110474Wellcome Trust 200861/Z/16/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Asymptomatic InfectionsHumansIncidenceInfluenza A virusInfluenza, HumanInfluenza VaccinesObservational Studies as TopicRandomized Controlled Trials as TopicResearch DesignVaccinationInfluenza Vaccinesbiascase-controlchallengescohortconfoundingeffectivenessInfluenzatest-negativevaccinationwaning

Identifiers

PMID31116070
PMCPMC6594904
OpenAlexW2946667882

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.